Amerigo Allegretto[email protected]UltrasoundARRS: Cancer status should be considered for axillary breast ultrasoundResearch shown at ARRS 2025 found that breast cancer status and exam indication should be considered when reading axillary ultrasound exams.May 5, 2025Womens ImagingARRS: Get involved with breast health advocacyAt ARRS 2025, Amy Patel, MD, discussed the need for advocacy to drive legislation on insurance coverage for women with dense breasts.May 2, 2025Womens ImagingARRS: Most women under 40 have no imaging before breast cancer diagnosisMost young women who are diagnosed with breast cancer had no prior imaging performed.May 1, 2025Womens ImagingMultidisciplinary breast cancer care improves time-to-treatmentMultidisciplinary breast cancer care improves time-to-treatment at safety net hospitals.May 1, 2025Womens ImagingARRS: Mobile mammo boosts breast screening, but no-show rate still highFree mobile screening mammography improves breast screening access for uninsured women, but doesn't lead to follow-up adherence.April 30, 2025Womens ImagingARRS: How to manage 'controversial' high-risk breast lesionsManaging high-risk breast lesions with no consensus can be tricky, but breast radiologists can navigate this area.April 30, 2025Womens ImagingARRS: Most women OK with mammo data used to assess cancer riskMost women are comfortable with having their mammogram data be used to calculate lifetime breast cancer riskApril 28, 2025UltrasoundLung POCUS helps diagnose dyspnea in emergency departmentsPoint-of-care lung ultrasound may be useful in the emergency department for diagnosing dyspnea.April 23, 2025MRIMRI tool segments over 60 abdominal organs, structuresAn automated multiorgan tool can accurately segment T1-weighted abdominal MR images.April 22, 2025Womens ImagingUkrainian refugees at higher risk of advanced breast cancersDisplaced Ukrainian women have double the odds of having advanced-stage breast cancer compared with Polish citizens.April 22, 2025Previous PagePage 3 of 57Next PageTop StoriesMolecular ImagingCase report: Pluvicto as a first-line treatment in late-stage prostate cancerSince 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.MRINew brain MRI imaging technique could help identify Alzheimer'sRadiology EducationScholarly activity low among residency program directorsDigital X-Ray3D DEXA shows value in patients with prostate cancerSponsor ContentDigital Innovations Shaping the Future of Radiology